Lead Product(s) : Raltitrexed
Therapeutic Area : Oncology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Raltitrexed is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Colorectal Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 09, 2013
Lead Product(s) : Raltitrexed
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
